Alogliptin (Benzoate) - CAS# 850649-62-6 683 small molecule modulators of IRE1α

small molecule modulators of IRE1α

[Pharmacokinetics and disposition of triptonide in rats]

[4] Bepotastine (3 mg/kg and 10 mg/kg) effectively inhibits the compound 48/80-induced scratching behavior of BALB/c mice 1 hour after oral administration

Chemical Name: 2-sulfanylethane-1-sulfonic acid sodium

EW-7197 Hydrochloride

Alogliptin (Benzoate) - CAS# 850649-62-6 683 small molecule modulators of IRE1αAlogliptin benzoate is a DPP 4 inhibitor used for the treatment of Type 2 diabetes. Like other members of the gliptin class, it causes little or no weight gain, exhibits relatively little risk of causing hypoglycemia, and exhibits relatively modest glucose lowering activity. Alogliptin and other gliptins are commonly used in combination with metformin in patients whose diabetes cannot adequately be controlled with metformin alone. Product information